7-Bromo-3H-imidazo[4,5-b]pyridine

Catalog No.: 
ACRPEY973
CAS No.: 
1207174-85-3
Molecular Formula: 
C6H4BrN3
Molecular Weight: 
198.02
7-Bromo-3H-imidazo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%
10g95%
25g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-3H-imidazo[4,5-b]pyridine
IUPAC Name7-bromo-3H-imidazo[4,5-b]pyridine
MDL No.MFCD11846335
Molecular FormulaC6H4BrN3
Molecular Weight198.02
SMILESBrC1=CC=NC2=C1N=CN2
InChI KeyDEFSPWZHYXXHLB-UHFFFAOYSA-N
Synonym7-Bromo-3H-imidazo[4,5-b]pyridine | 1207174-85-3 | 7-BROMO-1H-IMIDAZO[4,5-B]PYRIDINE | 7-Bromo-3H-imidazo[4,5-b]... | MFCD11846335 | 7-Bromoimidazo[4,5-b]pyridine | SCHEMBL1165562 | SCHEMBL21856245 | DTXSID00698421 | AKOS006342850 | PB16431 | DS-15430 | SY032534 | CS-0050085 | FT-07
CAS No.1207174-85-3
PubChem CID53423966

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRPEY973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIHTL382 route compound structure diagram
    ACIHTL3821232431-75-2In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2In Stock
  4. Then
  5. ACRPEY973 route product structure diagram
    ACRPEY9731207174-85-3In Stock
Inquiry

2. ACRPEY973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPEY973 route product structure diagram
    ACRPEY9731207174-85-3In Stock
Inquiry

3. ACRPEY973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPEY973 route product structure diagram
    ACRPEY9731207174-85-3In Stock
Inquiry

Comments (0)